408 related articles for article (PubMed ID: 34790198)
1. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E
Front Immunol; 2021; 12():754469. PubMed ID: 34790198
[TBL] [Abstract][Full Text] [Related]
2. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE
Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
[TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
4. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
5. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
Front Immunol; 2018; 9():2971. PubMed ID: 30619328
[No Abstract] [Full Text] [Related]
7. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
[TBL] [Abstract][Full Text] [Related]
8. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R
Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
[TBL] [Abstract][Full Text] [Related]
10. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant.
Bertolaccini ML; Sciascia S; Murru V; Garcia-Fernandez C; Sanna G; Khamashta MA
Thromb Haemost; 2013 Feb; 109(2):207-13. PubMed ID: 23254928
[TBL] [Abstract][Full Text] [Related]
13. Anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) increase the risk for thrombosis based on lupus anticoagulant positivity.
Zhang Y; Su Y; Guo H; Wang L; Li A; Wang C; Zhang J; Qiao R
Clin Biochem; 2023 Feb; 112():17-23. PubMed ID: 36535385
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I.
Sanfelippo MJ; Joshi A; Schwartz S; Meister JA; Goldberg JW
Lupus; 2013 Nov; 22(13):1349-52. PubMed ID: 23989738
[TBL] [Abstract][Full Text] [Related]
16. Laboratory Evaluation of Antiphospholipid Syndrome.
Heikal N; Martins TB; White SK; Willis R; Ware Branch D; Schmidt RL; Tebo AE
Am J Clin Pathol; 2019 Oct; 152(5):638-646. PubMed ID: 31305881
[TBL] [Abstract][Full Text] [Related]
17. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
[TBL] [Abstract][Full Text] [Related]
18. Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.
Borghi MO; Beltagy A; Garrafa E; Curreli D; Cecchini G; Bodio C; Grossi C; Blengino S; Tincani A; Franceschini F; Andreoli L; Lazzaroni MG; Piantoni S; Masneri S; Crisafulli F; Brugnoni D; Muiesan ML; Salvetti M; Parati G; Torresani E; Mahler M; Heilbron F; Pregnolato F; Pengo M; Tedesco F; Pozzi N; Meroni PL
Front Immunol; 2020; 11():584241. PubMed ID: 33178218
[TBL] [Abstract][Full Text] [Related]
19. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies.
Ofer-Shiber S; Molad Y
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):261-6. PubMed ID: 25526601
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
Uludağ Ö; Çinar S; McDonnell T; Çene E; Yalçinkaya Y; Gül A; Inanç M; Artim Esen B
Turk J Med Sci; 2023; 53(5):1067-1074. PubMed ID: 38813003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
